+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Beigene"

Nasopharyngeal Carcinoma Treatment Market Report 2026 - Product Thumbnail Image

Nasopharyngeal Carcinoma Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Metastatic Bone Disease Market Report 2026 - Product Thumbnail Image

Metastatic Bone Disease Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Drugs for Immunotherapy Market Report 2026 - Product Thumbnail Image

Drugs for Immunotherapy Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Liver Cancer Drug Market Report 2026 - Product Thumbnail Image

Liver Cancer Drug Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Antibody Drug Conjugate - Competitive Landscape, 2026 - Product Thumbnail Image

Antibody Drug Conjugate - Competitive Landscape, 2026

  • Report
  • April 2026
  • 280 Pages
  • Global
From
TIGIT Inhibitors - Competitive Landscape, 2026 - Product Thumbnail Image

TIGIT Inhibitors - Competitive Landscape, 2026

  • Report
  • January 2026
  • 100 Pages
  • Global
From
From
From
From
From
Myeloproliferative Neoplasms Pipeline Analysis Report 2026 - Product Thumbnail Image

Myeloproliferative Neoplasms Pipeline Analysis Report 2026

  • Report
  • May 2026
  • 200 Pages
  • Global
From
From
Oncology Drugs Market 2026-2030 - Product Thumbnail Image

Oncology Drugs Market 2026-2030

  • Report
  • August 2026
  • 316 Pages
  • Global
From
Ctla4 Inhibitors Market 2026-2030 - Product Thumbnail Image

Ctla4 Inhibitors Market 2026-2030

  • Report
  • May 2026
  • 283 Pages
  • Global
From
From
From
From
From
From
Loading Indicator

BeiGene is a market within the context of Oncology Drugs, which are drugs used to treat cancer. These drugs are used to target and destroy cancer cells, while minimizing damage to healthy cells. BeiGene is a biopharmaceutical company that develops and commercializes innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer. The company focuses on developing therapies that target cancer cells with precision and accuracy, while also providing a safe and effective treatment for patients. BeiGene's portfolio includes a range of drugs, including small molecules, antibodies, and other biologics. The company also has a pipeline of novel therapies in development. BeiGene is one of many companies in the Oncology Drugs market. Other companies include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more